Genomic risk distribution, adjuvant chemotherapy trends, and survival outcomes in women with pT1, grade 1-2, ER/PR-positive, LVI-negative breast cancer

Current Problems in Cancer · Published 2026-07-10 · DOI 10.1016/j.currproblcancer.2026.101318

Free full text

Authors (6)

Nickolas Stabellini, Maya Lubarsky, Ananya Munjal, Amanda L. Amin, Megan E. Miller, Alberto J. Montero

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Stabellini, N., Lubarsky, M., Munjal, A., et al. (2026). Genomic risk distribution, adjuvant chemotherapy trends, and survival outcomes in women with pT1, grade 1-2, ER/PR-positive, LVI-negative breast cancer. Current Problems in Cancer. https://doi.org/10.1016/j.currproblcancer.2026.101318

Related articles

• Efficacy of atezolizumab, bevacizumab, carboplatin, and paclitaxel for epidermal growth factor receptor mutation-positive advanced non-small cell lung cancer after tyrosine kinase inhibitor failure · Current Problems in Cancer · 2025 · Same journal
• Immune checkpoint expression and therapeutic implications in IDH1-mutant and wild-type glioblastomas · Current Problems in Cancer · 2025 · Same journal
• Outcomes for females versus males treated with eribulin mesylate for advanced urothelial carcinoma · Current Problems in Cancer · 2026 · Same journal
• A phase 2 prospective trial of re-irradiation of locally recurrent or second primary head and neck tumors using stereotactic body radiation therapy · Current Problems in Cancer · 2025 · Same journal
• Unraveling the microbiome’s role in breast cancer progression and treatment response · Current Problems in Cancer · 2025 · Same journal
• Multicenter retrospective study on the clinical profiles of patients with extensive-stage small-cell lung cancer who met the eligibility criteria for clinical trials · Current Problems in Cancer · 2026 · Same journal
• Patterns of care for older multiple myeloma patients in the U.S.: An analysis of the national cancer database · Current Problems in Cancer · 2026 · Same journal
• Immune-metabolic plasticity in AML: Prognostic roles of aCTLs (activated Cytotoxic T Cells) and Kynurenine · Current Problems in Cancer · 2026 · Same journal
• The current state of proton radiotherapy · Current Problems in Cancer · 2024 · Same journal
• Angiogenesis biomarkers in prostate cancer: Unlocking new avenues for prognosis and diagnosis · Current Problems in Cancer · 2025 · Same journal